e-learning
resources
Stockholm 2007
Monday 17.09.2007
Impact of comorbidities in pulmonary rehabilitation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Cumulatively predicting cardiovascular hospitalisation and death in COPD patients
W. Anderson, S. Schembri, J. Winter, P. Thompson, J. Winter, D. Pettitt, T. MacDonald (Dundee, United Kingdom; NY, United States Of America)
Source:
Annual Congress 2007 - Impact of comorbidities in pulmonary rehabilitation
Session:
Impact of comorbidities in pulmonary rehabilitation
Session type:
Oral Presentation
Number:
2682
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
W. Anderson, S. Schembri, J. Winter, P. Thompson, J. Winter, D. Pettitt, T. MacDonald (Dundee, United Kingdom; NY, United States Of America). Cumulatively predicting cardiovascular hospitalisation and death in COPD patients. Eur Respir J 2007; 30: Suppl. 51, 2682
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Predictors of mortality in COPD patients after hospitalization due to an exacerbation
Source: International Congress 2019 – Exacerbations of airway diseases
Year: 2019
Prior cardiovascular disease increases long-term mortality in COPD patients with pneumonia
Source: Eur Respir J 2014; 43: 36-42
Year: 2004
In-hospital causes of death in patients with COPD
Source: Annual Congress 2009 - Exacerbations and characteristics of COPD
Year: 2009
Accelerated FEV
1
decline and risk of cardiovascular disease and mortality in a primary care population of COPD patients
Source: Eur Respir J, 57 (3) 2000918; 10.1183/13993003.00918-2020
Year: 2021
β-blockers and risk of COPD exacerbation requiring hospitalisation in patients with COPD
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011
COPD the unseen factor causing increased morbidity and mortality among IHD patients
Source: Annual Congress 2009 - COPD case-finding and management in primary care
Year: 2009
Risk factors for mortality in patients with COPD exacerbation
Source: Annual Congress 2009 - Epidemiology of COPD
Year: 2009
Factors affecting one year mortality of hospitalized patients with COPD exacerbation and respiratory failure
Source: Eur Respir J 2007; 30: Suppl. 51, 321s
Year: 2007
Identifying risk groups for any cause hospitalizations in COPD patients
Source: International Congress 2017 – Highlights on clinical problems in COPD
Year: 2017
Preventing readmission of patients with COPD
Source: Annual Congress 2012 - Nursing led education and follow-up strategies: impact on readmission, self care and patient experiences
Year: 2012
No impact of statins on time to first COPD exacerbation or all-cause mortality
Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data
Year: 2021
Do cardiovascular drugs reduce mortality in patients with COPD in daily practice? A study in primary care
Source: Annual Congress 2007 - Management of COPD: pushing forward the boundaries in primary care
Year: 2007
Statins and outcome of COPD patients after hospitalization for COPD exacerbations
Source: Annual Congress 2010 - New treatments for asthma and COPD
Year: 2010
In hospitalized COPD exacerbation (COPDE) patients a 30-day readmission is associated with a progressive increased risk of mortality
Source: International Congress 2015 – COPD: interesting notes
Year: 2015
Risk factors for hospitalization of an acute exacerbation of COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 177s
Year: 2006
Key factors associated with readmission in COPD patients
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013
Risk factors of death in patients with COPD
Source: Annual Congress 2009 - Prognosis and comorbidities in COPD
Year: 2009
The impact on risk-factor analysis of different mortality outcomes in COPD patients
Source: Eur Respir J 2008; 32: 629-636
Year: 2008
Exacerbations and mortality of COPD patients with cardiovascular disease in the UK
Source: Annual Congress 2010 - Comorbidity in obstructive airway disease
Year: 2010
The main reasons of exacerbation and hospitalization of COPD patients
Source: Eur Respir J 2007; 30: Suppl. 51, 558s
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept